1,3-diisopropylcarbodiimide has been researched along with Hyperplasia in 2 studies
*Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
2 other study(ies) available for 1,3-diisopropylcarbodiimide and Hyperplasia
| Article | Year |
|---|---|
Toxicology study of diispropylcarbodiimide (CAS No. 693-13-0) in genetically modified (FVB Tg.AC Hemizygous) mice and carcinogenicity study of diispropylcarbodiimide in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (dermal studies)
Topics: Administration, Cutaneous; Animals; Carbodiimides; Carcinogenicity Tests; Female; Genes, ras; Hyperplasia; Mice; Mice, Transgenic; Skin; Tumor Suppressor Protein p53 | 2007 |
Toxicology and carcinogenesis studies of diisopropylcarbodiimide (Cas No. 693-13-0) in F344/N rats and B6C3F1 mice (dermal studies).
Topics: Administration, Cutaneous; Animals; Body Weight; Brain; Brain Diseases; Carbodiimides; Female; Hemorrhage; Hyperplasia; Male; Mice; Mice, Inbred Strains; Micronuclei, Chromosome-Defective; Mutagens; Occupational Exposure; Rats; Rats, Inbred F344; Seizures; Skin Diseases; Toxicity Tests; Xenobiotics | 2007 |